Literature DB >> 23553197

Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis.

Dorota Wickiewicz1, Agnieszka Chrobak, Grzegorz B Gmyrek, Alicja Halbersztadt, Marian S Gabryś, Marian Goluda, Anna Chełmońska-Soyta.   

Abstract

PURPOSE: To determine, with extended receiver operating characteristic (ROC) curve analysis, the diagnostic value of cytokines showing significantly different peritoneal concentrations between women with and without endometriosis.
METHODS: Multiplex cytokine concentration measurement of IL-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ levels in peritoneal fluid of women with minimal to mild (n = 10) and moderate to severe (n = 26) endometriosis, and 42 controls.
RESULTS: Only IL-6 and IL-10 concentrations were significantly higher in endometriosis patients than in controls. Specifically, significantly higher IL-6 and IL-10 levels were found in moderate to severe but not in minimal to mild endometriosis as compared to controls. For evaluation of diagnostic significance, ROC analysis determined discriminating parameters for IL-6, while those calculated for IL-10 were useless. Importantly, ROC analysis for IL-6 levels limited to women with moderate to severe endometriosis showed the highest area under the curve with the sample size sufficient to achieve 90 % power of the test. Finally, extended ROC including cost of analysis for this group of patients determined the optimal cut-off leading to high specificity and positive likelihood ratio resulting in 79 % effectiveness of the test.
CONCLUSIONS: While our outcomes show moderate usefulness of peritoneal IL-6 levels in discrimination of moderate to severe endometriosis, further studies might be needed to determine the usefulness of peritoneal IL-6 levels in detection of early stages of endometriosis, as such a finding would be more relevant in clinical decision making.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553197     DOI: 10.1007/s00404-013-2828-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

2.  Screening the role of pronociceptive molecules in a rodent model of endometriosis pain.

Authors:  Pedro Alvarez; Jon D Levine
Journal:  J Pain       Date:  2014-04-20       Impact factor: 5.820

3.  Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis.

Authors:  Andrei M Malutan; Tudor Drugan; Nicolae Costin; Razvan Ciortea; Carmen Bucuri; Maria P Rada; Dan Mihu
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

4.  Effect of A-317491 delivered by glycolipid-like polymer micelles on endometriosis pain.

Authors:  Ming Yuan; Shaojie Ding; Tingting Meng; Binbin Lu; Shihong Shao; Xinmei Zhang; Hong Yuan; Fuqiang Hu
Journal:  Int J Nanomedicine       Date:  2017-11-09

5.  Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls.

Authors:  Tamara Knific; Dmytro Fishman; Andrej Vogler; Manuela Gstöttner; René Wenzl; Hedi Peterson; Tea Lanišnik Rižner
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

6.  Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis.

Authors:  Izabela Kokot; Agnieszka Piwowar; Marcin Jędryka; Katarzyna Sołkiewicz; Ewa Maria Kratz
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

7.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13

Review 8.  The complementary and alternative medicine for endometriosis: a review of utilization and mechanism.

Authors:  Sai Kong; Yue-Hui Zhang; Chen-Fang Liu; Ilene Tsui; Ying Guo; Bei-Bei Ai; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-19       Impact factor: 2.629

9.  P2X3 receptor involvement in endometriosis pain via ERK signaling pathway.

Authors:  Shaojie Ding; Libo Zhu; Yonghong Tian; Tianhong Zhu; Xiufeng Huang; Xinmei Zhang
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

10.  Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?

Authors:  Shaojie Ding; Qiao Lin; Tianhong Zhu; Tiantian Li; Libo Zhu; Jianzhang Wang; Xinmei Zhang
Journal:  BMC Womens Health       Date:  2019-12-30       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.